XML 32 R17.htm IDEA: XBRL DOCUMENT v3.25.1
Long-term Receivables
12 Months Ended
Dec. 31, 2024
Receivables [Abstract]  
Long-term Receivables

7. Long-term Receivables

As of December 31, 2024, the Company had long-term receivables of $1,292,800 from two of the three licensees representing the present value of fixed guaranteed royalty payments that will be payable over varying periods of two through five years that commenced in the second half of 2022 and terminate in the second quarter of 2028. The fixed guaranteed royalty payments result from amendments to license agreements with two existing licensees and a license agreement with a new licensee. The receivable represents the present value of the fixed minimum annual payments due under the license agreements, discounted at the Company’s incremental borrowing rate of 6.32%.

The three agreements grant licenses for the use of certain patented ink technology as it exists at the time that it is granted which is considered functional intellectual property. Under Topic 606, a performance obligation to transfer a license for functional intellectual property is satisfied at a point in time and the fixed consideration could be recognized upfront when the Company transfers control of the licensee if certain criteria are met. Specifically, the minimum royalty guarantee could be recognized upfront if the following conditions are met:

·The royalty payment is fixed or determinable

·Collection of the royalty payment is considered probable

·The licensee has the ability to benefit from the licensed technology

The Company determined that the above conditions were met upon execution of the three license agreements. The commissions are payable over the term of the agreements and are due when payments are received by the Company. As of December 31, 2024 and 2023, the accrued commission payable balance was $128,500 and $172,200 included on the balance sheet in accrued expenses and accrued expenses, non-current.

The current portion of the three license agreements, in the amount of $545,700 and $624,600, is included in accounts receivable on the balance sheet as of December 31, 2024 and 2023.

The following table summarizes the future minimum payments due under the three license agreements as of December 31, 2024:

Schedule of future minimum payments     
Year Ending December 31:     
      
 2025   $570,000 
 2026   $570,000 
 2027   $557,500 
 2028   $260,000 
 Total   $1,957,500 

 

The Company has evaluated the collectability of the long-term receivables and believes them to be fully collectible as of December 31, 2024. However, there can be no assurance that the receivables will not be impaired in the future due to changes in the licensees’ financial condition or other factors.

The long-term receivables are recorded at its present value as of December 31, 2024, and the receivable and imputed interest will be amortized over the term of the license agreements using the effective interest method. The unamortized balance of the long-term receivables as of December 31, 2024 and 2023 is $1,292,800 and $1,838,500. The unamortized imputed interest balance as of December 31, 2024 and 2023 was $110,500 and $126,600, which will be recognized as interest income through June 30, 2028. Interest income was $16,100 and $18,600 for the year ended December 31, 2024 and 2023, respectively.